# Characterization of Argonaute-containing protein complexes in Leishmania-infected human macrophages

**Authors:** Atieh Moradimotlagh, Harsimran Kaur Brar, Stella Chen, Kyung-Mee Moon, Leonard J. Foster, Neil Reiner, Devki Nandan

PMC · DOI: 10.1371/journal.pone.0303686 · PLOS ONE · 2024-05-23

## TL;DR

This study explores how the Leishmania parasite alters RNA interference complexes in human macrophages, offering new insights into host-pathogen interactions and potential therapeutic targets.

## Contribution

The first comprehensive proteomic analysis of Argonaute-containing complexes in Leishmania-infected macrophages.

## Key findings

- Leishmania modulates the composition of host macrophage RISC complexes during infection.
- 51 Ago-interacting proteins with diverse biological functions were identified.
- Leishmania proteins were found integrated into host Ago-containing complexes in infected cells.

## Abstract

The intracellular protozoan parasite Leishmania causes leishmaniasis in humans, leading to serious illness and death in tropical and subtropical areas worldwide. Unfortunately, due to the unavailability of approved vaccines for humans and the limited efficacy of available drugs, leishmaniasis is on the rise. A comprehensive understanding of host-pathogen interactions at the molecular level could pave the way to counter leishmaniasis. There is growing evidence that several intracellular pathogens target RNA interference (RNAi) pathways in host cells to facilitate their persistence. The core elements of the RNAi system are complexes of Argonaute (Ago) proteins with small non-coding RNAs, also known as RNA-induced silencing complexes (RISCs). Recently, we have shown that Leishmania modulates Ago1 protein of host macrophages for its survival. In this study, we biochemically characterize the Ago proteins’ interactome in Leishmania-infected macrophages compared to non-infected cells. For this, a quantitative proteomic approach using stable isotope labelling by amino acids in cell culture (SILAC) was employed, followed by purification of host Ago-complexes using a short TNRC6 protein-derived peptide fused to glutathione S-transferase beads as an affinity matrix. Proteomic-based detailed biochemical analysis revealed Leishmania modulated host macrophage RISC composition during infection. This analysis identified 51 Ago-interacting proteins with a broad range of biological activities. Strikingly, Leishmania proteins were detected as part of host Ago-containing complexes in infected cells. Our results present the first report of comprehensive quantitative proteomics of Ago-containing complexes isolated from Leishmania-infected macrophages and suggest targeting the effector complex of host RNAi machinery. Additionally, these results expand knowledge of RISC in the context of host-pathogen interactions in parasitology in general.

## Linked entities

- **Proteins:** Argonaute (Argonaute), AGO1 (argonaute RISC component 1), TNRC6A (trinucleotide repeat containing adaptor 6A)
- **Diseases:** leishmaniasis (MONDO:0011989)
- **Species:** Leishmania (taxon 5658), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TNRC6A (trinucleotide repeat containing adaptor 6A) [NCBI Gene 27327] {aka CAGH26, FAME6, GW1, GW182, TNRC6}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, AGO1 (argonaute RISC component 1) [NCBI Gene 26523] {aka EIF2C, EIF2C1, GERP95, NEDLBAS, Q99, hAgo1}
- **Diseases:** death (MESH:D003643), leishmaniasis (MESH:D007896), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Leishmania (subgenus) [taxon 38568]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11115314/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11115314/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC11115314/full.md

---
Source: https://tomesphere.com/paper/PMC11115314